Alessandra Larocca

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Newly Diagnosed

Ejection Fraction

Multiple Myeloma

Top Venues

Blood cancer journal

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Schjesvold Fredrik, Heinz Ludwig, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Haifaa Abdulhaq, Stefan Norin, Marcus Thuresson, Nicolaas A Bakker, Paul Gerard Richardson, Pieter Sonneveld
Melflufen in relapsed/refractory multiple myeloma refractory to prior alkylators: A subgroup analysis from the OCEAN study. European journal of haematology (2023)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota-Scalabrini, Francesca Bonello, Caterina Musolino, Michele Cea, Renato Zambello, Paola Tacchetti, Angelo Belotti, Claudia Cellini, Laura Paris, Mariella Grasso, Sara Aquino, Lorenzo De Paoli, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Mario Boccadoro, Federico Monaco, Paolo Corradini, Alessandra Larocca
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. Blood cancer journal 11 (12) (2021)
Alessandra Larocca, Francesca Bonello, Gianluca Gaidano, Mattia D'Agostino, Massimo Offidani, Nicola Cascavilla, Andrea Capra, Giulia Benevolo, Patrizia Tosi, Monica Galli, Roberto Marasca, Nicola Giuliani, Annalisa Bernardini, Elisabetta Antonioli, Delia Rota-Scalabrini, Claudia Cellini, Alessandra Pompa, Federico Monaco, Francesca Patriarca, Tommaso Caravita di Toritto, Paolo Corradini, Paola Tacchetti, Mario Boccadoro, Sara Bringhen
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma. Blood 137 (22) (2021)
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Pellegrino Musto, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. Blood cancer journal 11 (4) (2021)
Evangelos Terpos, Joseph Mikhael, Roman Hájek, Ajai Chari, Sonja Zweegman, Hans C Lee, Maria-Victoria Mateos-Manteca, Alessandra Larocca, Karthik Ramasamy, Martin F Kaiser, Gordon Cook, Katja C Weisel, Caitlin L Costello, Jennifer Elliott, Antonio Palumbo, Saad Z Usmani
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. Blood cancer journal 11 (2) (2021)
Alessandra Larocca, Xavier Leleu, Cyrille Touzeau, Joan Bladé, Agne Paner, Maria-Victoria Mateos-Manteca, Michele Cavo, Christopher Maisel, Adrían Alegre, Albert Oriol, Anastasios Raptis, Paula Rodriguez Otero, Amitabha Mazumder, Jacob P Laubach, Omar Nadeem, Anna Sandberg, Marie Orre, Anna Torrång, Nicolaas A Bakker, Paul Gerard Richardson
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. British journal of haematology (2021)
Roberto Mina, Angelo Belotti, Maria Teresa Petrucci, Renato Zambello, Andrea Capra, Giacomo Di Lullo, Sonia Ronconi, Norbert Pescosta, Mariella Grasso, Federico Monaco, Claudia Cellini, Marco Gobbi, Stelvio Ballanti, Paolo de Fabritiis, Maria Letizia Mosca-Siez, Monia Marchetti, Anna Marina Liberati, Massimo Offidani, Nicola Giuliani, Roberto Ria, Pellegrino Musto, Alessandra Romano, Pieter Sonneveld, Mario Boccadoro, Alessandra Larocca
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. Blood cancer journal 10 (5) (2020)
Mattia D'Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Even Holth Rustad, Elisa Genuardi, Andrea Capra, Stefania Oliva, Daniel Auclair, Jennifer Yesil, Paola Colucci, Jonathan J Keats, Manuela Gambella, Sara Bringhen, Alessandra Larocca, Mario Boccadoro, Niccolo' Bolli, Francesco Maura, Francesca Gay
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Alessandra Larocca, Mattia D'Agostino, Mario Boccadoro
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients. British journal of haematology 182 (2) (2018)